Poster – Non-Invasive Serum Lipidomic Approach To Discriminate Non-Alcoholic Steatohepatitis (NASH) In Multiethnic Patients With Type 2 Diabetes Mellitus

Created: January 15, 2025

Despite the growing prevalence of NASH, there are currently no approved treatments for the disease beyond liver transplant. The constellation of risk factors for NASH has generated a multitude of targets and there is an obvious need to bring promising treatments through clinical trials and to patients quickly.

Reach out to our experts and discover how we can help you advance your research